October 2013 FDA Recall Drug by Sandoz, Inc
D-66458-1 - Cross contamination with other products

This Class II drug recall was voluntarily initiated by Sandoz, Inc on October 9, 2013 for the product Drug. The FDA reported the reason for recall as cross contamination with other products. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-66458-1

Reason for Recall
Cross contamination with other products: Sandoz is recalling certain lots of Ropinirole Extended Release Tablets 2 mg due to the potential presence of carryover coming from the previously manufactured product, mycophenolate mofetil.
Initiated
10-09-2013
Reported
11-13-2013
Quantity
692 bottles (90 count)

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Ropinirole, extended-release tablets, 2 mg, 90 count bottle, Rx only, Manufactured in India by Sandoz Private Ltd, for Sandoz Inc, Princeton, NJ 08540, NDC 0781-5780-92

Batch or Lot Expiration Information

Lot# Lot DJ2744, Exp 12/2014